Annalisa Saracino Selected Research

Annalisa Saracino Research Topics

Disease

29	COVID-19 04/2024 - 01/2020
29	Infections 01/2024 - 01/2007
8	Acquired Immunodeficiency Syndrome (AIDS) 01/2023 - 08/2003
8	HIV Infections (HIV Infection) 05/2022 - 12/2005
7	Sepsis (Septicemia) 01/2024 - 08/2021
6	Disease Progression 01/2024 - 05/2021
6	Coinfection 10/2022 - 01/2007
5	Pneumonia (Pneumonitis) 11/2021 - 10/2018
5	Chronic Hepatitis C 03/2020 - 01/2005
4	Tuberculosis (Tuberculoses) 02/2024 - 01/2017
4	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 07/2021
4	Communicable Diseases (Infectious Diseases) 08/2022 - 01/2020
3	Malaria 12/2023 - 07/2012
3	Opportunistic Infections (Opportunistic Infection) 01/2023 - 07/2012
3	Neoplasms (Cancer) 01/2023 - 03/2015
3	Inflammation (Inflammations) 04/2017 - 05/2013
3	Chronic Hepatitis (Chronic Active Hepatitis) 10/2008 - 01/2005
2	Renal Insufficiency (Renal Failure) 01/2024 - 11/2021
2	Endocarditis 12/2023 - 08/2021
2	Healthcare-Associated Pneumonia 11/2023 - 06/2023
2	Drug-Related Side Effects and Adverse Reactions 11/2023 - 07/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2023 - 06/2021
2	Pruritus (Itching) 01/2023 - 08/2022
2	Multiple Sclerosis 11/2022 - 01/2020
2	Pulmonary Tuberculosis 11/2022 - 02/2018
2	Severe Acute Respiratory Syndrome 05/2022 - 05/2021
2	Liver Diseases (Liver Disease) 12/2021 - 01/2019
2	Alcoholism (Alcohol Abuse) 12/2021 - 01/2017
2	Fibrosis (Cirrhosis) 11/2021 - 01/2019
2	Critical Illness (Critically Ill) 05/2021 - 01/2021
2	Chronic Disease (Chronic Diseases) 01/2021 - 04/2017
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 07/2016
2	Lymphadenopathy 01/2019 - 10/2018
2	Hepatitis 01/2017 - 05/2006
2	Chronic Hepatitis B 09/2006 - 07/2005
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 04/2024
1	Mental Disorders (Mental Disorder) 04/2024
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 02/2024
1	Myocarditis (Carditis) 02/2024
1	Hypercholesterolemia 01/2024
1	Bradycardia 01/2024
1	Seizures (Absence Seizure) 01/2024

Drug/Important Bio-Agent (IBA)

11	RNA (Ribonucleic Acid)IBA 10/2023 - 07/2016
8	Antiviral Agents (Antivirals)IBA 12/2021 - 01/2007
6	Carbapenems (Carbapenem Antibiotics)IBA 01/2024 - 05/2021
6	ceftazidime drug combination avibactamIBA 11/2023 - 05/2021
5	InterferonsIBA 12/2023 - 01/2005
5	Anti-Bacterial Agents (Antibiotics)IBA 06/2023 - 03/2021
5	Ribavirin (Virazole)FDA LinkGeneric 01/2018 - 01/2005
4	Interleukin-6 (Interleukin 6)IBA 01/2024 - 05/2013
4	CefiderocolIBA 08/2023 - 03/2021
4	Oxygen (Dioxygen)IBA 01/2023 - 01/2021
3	lipoarabinomannan (LAM)IBA 02/2024 - 05/2006
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 05/2013
3	remdesivirIBA 01/2024 - 01/2023
3	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 11/2023 - 07/2012
3	Ritonavir (Norvir)FDA Link 01/2017 - 08/2003
3	Lamivudine (Epivir)FDA Link 09/2006 - 07/2005
2	mRNA VaccinesIBA 12/2023 - 05/2022
2	Cephalosporins (Cephalosporin Antibiotics)IBA 12/2023 - 03/2021
2	Immune Checkpoint InhibitorsIBA 09/2023 - 06/2021
2	Colistin (Coly-Mycin)FDA Link 08/2023 - 06/2023
2	sotrovimabIBA 01/2023 - 01/2023
2	ProcalcitoninIBA 01/2023 - 10/2022
2	Monoclonal AntibodiesIBA 01/2023 - 01/2023
2	Aztreonam FDA LinkGeneric 10/2022 - 03/2022
2	Antimalarials (Antimalarial Agents)IBA 08/2022 - 07/2012
2	VaccinesIBA 05/2022 - 01/2021
2	AntibodiesIBA 05/2022 - 05/2021
2	carbapenemaseIBA 03/2022 - 11/2021
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2021 - 01/2007
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 05/2021
2	Immunoglobulin G (IgG)IBA 05/2021 - 01/2015
2	dalbavancinIBA 05/2021 - 12/2020
2	fibrin fragment D (D-dimer)IBA 01/2021 - 12/2014
2	CreatinineIBA 11/2020 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2007
2	Viral RNAIBA 01/2019 - 01/2018
2	dasabuvirIBA 01/2017 - 07/2016
2	ombitasvirIBA 01/2017 - 07/2016
2	paritaprevirIBA 01/2017 - 07/2016
2	Peptide Hydrolases (Proteases)FDA Link 07/2009 - 12/2005
2	Interferon-alpha (Interferon Alfa)IBA 01/2008 - 09/2006
1	dolutegravirIBA 04/2024
1	Third Generation CephalosporinsIBA 01/2024
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2024
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2024
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 01/2024
1	Messenger RNA (mRNA)IBA 12/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2023
1	Interferon Type IIBA 12/2023
1	ProteomeIBA 12/2023

Therapy/Procedure

34	Therapeutics 02/2024 - 01/2005
5	Art Therapy 04/2024 - 07/2012
3	Immunotherapy 09/2023 - 06/2021
3	Length of Stay 05/2022 - 05/2021
2	Critical Care (Surgical Intensive Care) 01/2024 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2023 - 05/2022
1	Retention in Care 02/2024
1	Ketogenic Diet 01/2024